The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
The Role of Progesterone Receptors in Breast Cancer
Open accessAbstract
The progesterone receptor (PR) modulates estrogen receptors α (ERα) action in breast cancer; it is an upregulated target gene of ER, and its expression is dependent on estrogen. PR is also a valuable prognostic biomarker in breast cancer, especially in hormone-positive breast cancer. High expression of PR is more frequently observed in tumors with a better baseline prognosis (ie, luminal A) than tumors with a poor baseline prognosis (ie, luminal B). In the following review, we present the role of PR in breast cancer, including the genomic characteristics and pathways in breast cancer, PR and endocrine therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Shyamala, G., Conneely, O. M., & O'Malley, B. W. (1995) · Genes & Development · doi:10.1101/gad.9.18.2266 · Cited by 1,862
kConFab, Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., Asselin-Labat, M.-L., Gyorki, D. E., Ward, T., et al. (2009) · Nature Medicine · doi:10.1038/nm.2000 · Cited by 1,492 · cited 1×
“Is it the essential step from hyperplasia to ductal carcinoma in situ or invasive breast cancer? Is it the essential process for hormone-negative breast carcinogenesis? Previous research indicated that breast cancer with the harmful breast cancer 1 (BRCA1) variant is more likely to be hormone receptor negative, and BR…”
BackgroundBlows, F. M., Driver, K. E., Schmidt, M. K., Broeks, A., van Leeuwen, F. E., Wesseling, J., Cheang, M. C., Gelmon, K., Nielsen, T. O., Blomqvist, C., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000279 · Cited by 1,116
Wirapati, P., Sotiriou, C., Kunkel, S., Farmer, P., Pradervand, S., Haibe-Kains, B., Desmedt, C., Ignatiadis, M., Sengstag, T., Schütz, F., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr2124 · Cited by 891
Bardou, V.-J., Arpino, G., Elledge, R. M., Osborne, C. K., & Clark, G. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.099 · Cited by 752
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
Francis, P. A., Pagani, O., Fleming, G. F., Walley, B. A., Colleoni, M., Láng, I., Gómez, H. L., Tondini, C., Ciruelos, E., Burstein, H. J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1803164 · Cited by 684
Progesterone receptor modulates ERα action in breast cancer
Mohammed, H., Russell, I. A., Stark, R., Rueda, O. M., Hickey, T. E., Tarulli, G. A., Serandour, A. A., Birrell, S. N., Bruna, A., Saadi, A., et al. (2015) · Nature · doi:10.1038/nature14583 · Cited by 659
Migliaccio, A., Piccolo, D., Castoria, G., Di Domenico, M., Bilancio, A., Lombardi, M., Gong, W., Beato, M., & Auricchio, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.2008 · Cited by 626
Dissociation between steroid receptor expression and cell proliferation in the human breast.
Clarke, R. B., Howell, A., Potten, C. S., & Anderson, E. J. (1997) · PubMed · Cited by 625
RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis
Gonzalez-Suarez, E., Jacob, A. P., Jones, J., Miller, R., Roudier-Meyer, M. P., Erwert, R., Pinkas, J., Branstetter, D., & Dougall, W. C. (2010) · Nature · doi:10.1038/nature09495 · Cited by 596
Prat, A., Cheang, M. C. U., Martín, M., Parker, J. S., Carrasco, E., Caballero, R., Tyldesley, S., Gelmon, K., Bernard, P. S., Nielsen, T. O., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.4134 · Cited by 587
Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform
Mulac-Jericevic, B., Lydon, J. P., DeMayo, F. J., & Conneely, O. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732707100 · Cited by 547
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
Cui, X., Schiff, R., Arpino, G., Osborne, C. K., & Lee, A. V. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.004 · Cited by 514
Arpino, G., Weiss, H., Lee, A. V., Schiff, R., De Placido, S., Osborne, C. K., & Elledge, R. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji249 · Cited by 484
A paracrine role for the epithelial progesterone receptor in mammary gland development
Brisken, C., Park, S., Vass, T., Lydon, J. P., O’Malley, B. W., & Weinberg, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5076 · Cited by 479
Janku, F., Wheler, J. J., Westin, S. N., Moulder, S. L., Naing, A., Tsimberidou, A. M., Fu, S., Falchook, G. S., Hong, D. S., Garrido-Laguna, I., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1196 · Cited by 447
Mallepell, S., Krust, A., Chambon, P., & Brisken, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510974103 · Cited by 432
Immunohistochemistry of Estrogen and Progesterone Receptors Reconsidered
Nadji, M., Gomez-Fernandez, C., Ganjei-Azar, P., & Morales, A. R. (2005) · American Journal of Clinical Pathology · doi:10.1309/4wv7-9n2g-hj3x-1841 · Cited by 426
Clark, G. M., Osborne, C. K., & McGuire, W. L. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.10.1102 · Cited by 392
Reproductive Functions of Progesterone Receptors
Conneely, O. M. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.339 · Cited by 376
Giangrande, P. H., A. Kimbrel, E., Edwards, D. P., & McDonnell, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3102-3115.2000 · Cited by 376
Wen, D. X., Xu, Y. F., Mais, D. E., Goldman, M. E., & McDonnell, D. P. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8356 · Cited by 355
Nuclear-Receptor Ligands and Ligand-Binding Domains
Weatherman, R. V., Fletterick, R. J., & Scanlan, T. S. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.559 · Cited by 322
Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland
Beleut, M., Rajaram, R. D., Caikovski, M., Ayyanan, A., Germano, D., Choi, Y., Schneider, P., & Brisken, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915148107 · Cited by 307
Gao, J. J., Cheng, J., Bloomquist, E., Sanchez, J., Wedam, S. B., Singh, H., Amiri-Kordestani, L., Ibrahim, A., Sridhara, R., Goldberg, K. B., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30804-6 · Cited by 289
Condon, J. C., Hardy, D. B., Kovaric, K., & Mendelson, C. R. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0242 · Cited by 288
Physiology, production and action of progesterone
Taraborrelli, S. (2015) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12771 · Cited by 274
Dowsett, M., Cuzick, J., Wale, C., Howell, T., Houghton, J., & Baum, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4829 · Cited by 260
Merlino, A. A., Welsh, T. N., Tan, H., Yi, L. J., Cannon, V., Mercer, B. M., & Mesiano, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0077 · Cited by 259
Mote, P. A., Bartow, S., Tran, N., & Clarke, C. L. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1014820500738 · Cited by 255
Progesterone signalling in breast cancer: a neglected hormone coming into the limelight
Brisken, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3518 · Cited by 255
Luminal-B breast cancer and novel therapeutic targets
Tran, B., & Bedard, P. L. (2011) · Breast Cancer Research · doi:10.1186/bcr2904 · Cited by 249
Non-genomic progesterone actions in female reproduction
Gellersen, B., Fernandes, M. S., & Brosens, J. J. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn044 · Cited by 221
Hopp, T. A., Weiss, H. L., Hilsenbeck, S. G., Cui, Y., Allred, D. C., Horwitz, K. B., & Fuqua, S. A. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0141 · Cited by 220
Chlebowski, R. T., Rohan, T. E., Manson, J. E., Aragaki, A. K., Kaunitz, A., Stefanick, M. L., Simon, M. S., Johnson, K. C., Wactawski-Wende, J., O’Sullivan, M. J., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0494 · Cited by 211
Tan, H., Yi, L., Rote, N. S., Hurd, W. W., & Mesiano, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3251 · Cited by 209
Khodarev, N. N., Roizman, B., & Weichselbaum, R. R. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3225 · Cited by 203
PIK3CAmutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
Cizkova, M., Susini, A., Vacher, S., Cizeron-Clairac, G., Andrieu, C., Driouch, K., Fourme, E., Lidereau, R., & Bièche, I. (2012) · Breast Cancer Research · doi:10.1186/bcr3113 · Cited by 186
Fournier, A., Fabre, A., Mesrine, S., Boutron-Ruault, M.-C., Berrino, F., & Clavel-Chapelon, F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.4338 · Cited by 183
Lange, C. A., Richer, J. K., & Horwitz, K. B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0290 · Cited by 181
Tetel, M. J., Giangrande, P. H., Leonhardt, S. A., McDonnell, D. P., & Edwards, D. P. (1999) · Molecular Endocrinology · doi:10.1210/me.13.6.910 · Cited by 172
Characterization of progesterone receptor A and B expression in human breast cancer.
Graham, J. D., Yeates, C., Balleine, R. L., Harvey, S. S., Milliken, J. S., Bilous, A. M., & Clarke, C. L. (1995) · PubMed · Cited by 170
Li, Y., Yang, D., Yin, X., Zhang, X., Huang, J., Wu, Y., Wang, M., Yi, Z., Li, H., Li, H., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.18160 · Cited by 158
Faivre, E. J., Daniel, A. R., Hillard, C. J., & Lange, C. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0437 · Cited by 156
Clinicopathologic Analysis of Breast Cancers with PIK3CA Mutations in Japanese Women
Maruyama, N., Miyoshi, Y., Taguchi, T., Tamaki, Y., Monden, M., & Noguchi, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0267 · Cited by 152
Pagani, O., Francis, P. A., Fleming, G. F., Walley, B. A., Viale, G., Colleoni, M. A., Láng, I., Gómez, H., Tondini, C. A., Pinotti, G., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01967 · Cited by 149
Jacobsen, B. M., Schittone, S. A., Richer, J. K., & Horwitz, K. B. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0287 · Cited by 148
Mitogen-Activated Protein Kinase Regulates Nuclear Association of Human Progesterone Receptors
Qiu, M., Olsen, A. L., Faivre, E. J., Horwitz, K. B., & Lange, C. A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0378 · Cited by 141
Estrogen receptor expression of benign breast epithelium and its association with breast cancer.
Khan, S. A., Rogers, M. A. M., Obando, J. A., & Tamsen, A. (1994) · PubMed · Cited by 138
Boonyaratanakornkit, V., BI, Y., Rudd, M. D., & EDWARDS, D. (2008) · Steroids · doi:10.1016/j.steroids.2008.01.010 · Cited by 132
Osborne, C. K., Schiff, R., Arpino, G., Lee, A. S., & Hilsenbeck, V. G. (2005) · The Breast · doi:10.1016/j.breast.2005.08.024 · Cited by 117
Liu, Z., Wong, J., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231474798 · Cited by 112
Does Estrogen Receptor–Negative/Progesterone Receptor–Positive Breast Carcinoma Exist?
Maeyer, L. D., Limbergen, E. V., Nys, K. D., Moerman, P., Pochet, N. L. M. M., Hendrickx, W., Wildiers, H. P. M. W., Paridaens, R., Smeets, A., Christiaens, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8411 · Cited by 106
Knutson, T. P., Daniel, A. R., Fan, D., Silverstein, K. A. T., Covington, K. R., Fuqua, S. A. W., & Lange, C. A. (2012) · Breast Cancer Research · doi:10.1186/bcr3211 · Cited by 102
Activation of rapid oestrogen signalling in aggressive human breast cancers
Poulard, C., Treilleux, I., Lavergne, E., Bouchekioua‐Bouzaghou, K., Goddard‐Léon, S., Chabaud, S., Trédan, O., Corbo, L., & Romancer, M. L. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201615 · Cited by 98
The N-terminal Region of the Human Progesterone A-receptor
Bain, D. L., Franden, M. A., McManaman, J. L., Takimoto, G. S., & Horwitz, K. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7313 · Cited by 93
Nuclear localization signals also mediate the outward movement of proteins from the nucleus.
Guiochon‐Mantel, A., Delabre, K., Lescop, P., & Milgröm, E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7179 · Cited by 93
Role of phosphorylation in progesterone receptor signaling and specificity
Hagan, C. R., Daniel, A. R., Dressing, G. E., & Lange, C. A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.017 · Cited by 89
Selli, Ç., Dixon, J. M., & Sims, A. H. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0779-0 · Cited by 88
Bach, K., Pensa, S., Zarocsinceva, M., Kania, K., Stockis, J., Pinaud, S., Lazarus, K. A., Shehata, M., Simões, B. M., Greenhalgh, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21783-3 · Cited by 86
Fu, X., Giretti, M. S., Baldacci, C., Garibaldi, S., Flamini, M. I., Sanchez, A. M., Gadducci, A., Genazzani, A. R., & Simoncini, T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002790 · Cited by 85
The N-terminal Region of Human Progesterone B-receptors
Bain, D. L., Franden, M. A., McManaman, J. L., Takimoto, G. S., & Horwitz, K. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102611200 · Cited by 69
Systemic distribution of progesterone receptor subtypes in human tissues
Asavasupreechar, T., Saito, R., Miki, Y., Edwards, D. P., Boonyaratanakornkit, V., & Sasano, H. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105599 · Cited by 67
Rojas, P. A., May, M., Sequeira, G. R., Elia, A. M., Alvarez, M., Martínez, P., Gonzalez, P., Hewitt, S. M., He, X., Perou, C. M., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw317 · Cited by 66
Finlay-Schultz, J., Gillen, A. E., Brechbuhl, H. M., Ivie, J., Matthews, S. B., Jacobsen, B. M., Bentley, D. L., Kabos, P., & Sartorius, C. A. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3541 · Cited by 66
Calvo, V., & Beato, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3670 · Cited by 62
Alternative splicing and the progesterone receptor in breast cancer
Cork, D. M. W., Lennard, T. W. J., & Tyson-Capper, A. J. (2008) · Breast Cancer Research · doi:10.1186/bcr2097 · Cited by 62
Classical and Non-Classical Progesterone Signaling in Breast Cancers
Pedroza, D. A., Subramani, R., & Lakshmanaswamy, R. (2020) · Cancers · doi:10.3390/cancers12092440 · Cited by 56
Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women
Trabert, B. L., Bauer, D. C., Buist, D. S. M., Cauley, J. A., Falk, R. T., Geczik, A. M., Gierach, G. L., Hada, M., Hue, T. F., Lacey, J. V., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.3645 · Cited by 55
Molenda‐Figueira, H. A., Murphy, S. D., Shea, K. L., Siegal, N. K., Zhao, Y., Chadwick, J. G., Denner, L. A., & Tetel, M. J. (2008) · Endocrinology · doi:10.1210/en.2008-0048 · Cited by 51
Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer
Goodman, M. L., Trinca, G. M., Walter, K. R., Papachristou, E. K., D’Santos, C. S., Li, T., Liu, Q., Lai, Z., Chalise, P., Madan, R., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801152 · Cited by 51
Cenciarini, M. E., & Proietti, C. J. (2019) · Steroids · doi:10.1016/j.steroids.2019.108503 · Cited by 51
A Novel Antiestrogenic Mechanism in Progesterone Receptor-transfected Breast Cancer Cells
Zheng, Z.-Y., Bay, B., Aw, S.-E., & Lin, V. C. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501261200 · Cited by 49
Silva, J. S., Georgiade, G. S., Dilley, W. G., McCarty, K. S., Wells, S. A., & McCarty, K. S. (1983) · Cancer · Cited by 47
Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome
Baños, G., Guarner‐Lans, V., & Pérez-Torres, I. (2011) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/187152511797037547 · Cited by 40
The Role of Steroid Hormones in Breast and Effects on Cancer Stem Cells
Alférez, D., Simões, B. M., Howell, S. J., & Clarke, R. B. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0114-z · Cited by 38
PRMT1 Is Critical for the Transcriptional Activity and the Stability of the Progesterone Receptor
Malbeteau, L., Poulard, C., Languilaire, C., Mikaélian, I., Flamant, F., Romancer, M. L., & Corbo, L. (2020) · iScience · doi:10.1016/j.isci.2020.101236 · Cited by 36
Heneghan, A. F., Connaghan, K. D., Miura, M. T., & Bain, D. L. (2007) · Biochemistry · doi:10.1021/bi700850v · Cited by 30
Chung, H. H., Sze, S. K., Tay, A. S. L., & Lin, V. C. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517896 · Cited by 28
Hasan, T. N., Masoodi, Grace, Shafi, & Alshatwi, A. A. (2011) · Advances and Applications in Bioinformatics and Chemistry · doi:10.2147/aabc.s17371 · Cited by 22
Cucuzza, L. S., Divari, S., Mulasso, C., BIOLATTI, B., & Cannizzo, F. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113950 · Cited by 14
Bonneterre, J. M., Bosq, J., Jamme, P., Valent, A., Gilles, E. M., Zukiwski, A. A., Fuqua, S. A. W., Lange, C. A., & O’Shaughnessy, J. (2016) · ESMO Open · doi:10.1136/esmoopen-2016-000072 · Cited by 12
Epigenetic regulation of progesterone receptors and the onset of labour
Ilicic, M., Zakár, T., & Paúl, J. (2019) · Reproduction Fertility and Development · doi:10.1071/rd18392 · Cited by 12
Recouvreux, M. S., Bessone, M. I. D., Taruselli, A., Todaro, L. B., Huvelle, M. A. L., Sampayo, R. G., Bissell, M. J., & Simian, M. (2020) · Cells · doi:10.3390/cells9092074 · Cited by 11
Pateetin, P., Hutvágner, G., Bajan, S., Padula, M. P., McGowan, E. M., & Boonyaratanakornkit, V. (2021) · Scientific Data · doi:10.1038/s41597-021-00884-0 · Cited by 11
A Role for Site-Specific Phosphorylation of Mouse Progesterone Receptor at Serine 191 in Vivo
Grimm, S. L., Ward, R. D., Obr, A. E., Franco, H. L., Fernandez‐Valdivia, R., Kim, J., Roberts, J. M., Jeong, J., DeMayo, F. J., Lydon, J. P., et al. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1206 · Cited by 7
Metadata
- Authors
- Li, Z., Wei, H., Li, S., Wu, P., & Mao, X.
- Venue
- Drug Design, Development and Therapy
- Publisher
- Informa UK Limited
- Published
- 2022-01
- Volume
- Volume 16
- Pages
- 305-314
- ISSN
- 1177-8881 (ISSN-L)
- OpenAlex
- W4206995975
- Cited by
- 264
- References
- 89
- FWCI
- 17.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.